IncellDx, GeneCell Ink Pact to Offer HPV Test in India | GenomeWeb

NEW YORK (GenomeWeb News) – IncellDx today said it has reached a deal to offer its molecular diagnostic test for human papillomavirus in India.

Under the terms of the deal, New Delhi-based GeneCell Diagnostics will offer IncellDx's test for detecting oncogenic HPV E6, E7 mRNA through its laboratory partner CureHealth Diagnostics, which will be the first reference lab in India to offer the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.